Bioinformatics Analysis of Domain 1 of HCV-Core Protein: Iran

Aghasadeghi M, Sadat S, Budkowska A, Khabiri A, Amini S, Bahramali G et al (2006) Evaluation of a native preparation of HCV core protein (2-122) for potential applications in immunization, diagnosis and mAb production. Iran J Public Health 35(1):1–10 Ajorloo M, Bamdad T, Hashempour T, Alborzi AM, Mozhgani SHR, Asadi R et al (2015) Detection of specific antibodies to HCV-ARF/CORE + 1 protein in cirrhotic and non-cirrhotic patients with hepatitis C: a possible association with progressive fibrosis. Arch Iran Med AIM 18(5):304–307 Akuta N, Suzuki F, Kawamura Y, Yatsuji H, Sezaki H, Suzuki Y et al (2007) Amino acid substitutions in the hepatitis C virus core region are the important predictor of hepatocarcinogenesis. Hepatology 46(5):1357–1364 Akuta N, Suzuki F, Hirakawa M, Kawamura Y, Yatsuji H, Sezaki H et al (2010) Amino acid substitution in hepatitis C virus core region and genetic variation near the interleukin 28B gene predict viral response to telaprevir with peginterferon and ribavirin. Hepatology 52(2):421–429 Akuta N, Suzuki F, Hirakawa M, Kawamura Y, Sezaki H, Suzuki Y et al (2011) Amino acid substitutions in hepatitis C virus core region predict hepatocarcinogenesis following eradication of HCV RNA by antiviral therapy. J Med Virol 83(6):1016–1022 Alborzi AM, Bamdad T, Davoodian P, Hashempoor T, Nejatizadeh AA, Moayedi J (2015) Insights into the role of HCV Plus-/Minus strand RNA, IFN-γ and IL-29 in relapse outcome in patients infected with HCV. Asian Pac J Allergy Immunol 33(3):173–181 Alborzi A, Hashempour T, Moayedi J, Musavi Z, Pouladfar G, Merat S (2017) Role of serum level and genetic variation of IL-28B in interferon responsiveness and advanced liver disease in chronic hepatitis C patients. Med Microbiol Immunol 206(2):165–174 Alestig E, Arnholm B, Eilard A, Lagging M, Nilsson S, Norkrans G et al (2011) Core mutations, IL28B polymorphisms and response to peginterferon/ribavirin treatment in Swedish patients with hepatitis C virus genotype 1 infection. BMC Infect Dis 11(1):124 Arashkia A, Rouhvand F, Memarnejadian A, Alizadeh S, Motevalli F, Ebrahimi M (2011) Immunoinformatics modeling, construction of DNA plasmids Carrying CTL epitopes of hepatitis C virus and their preliminary immunological analysis. Iran J Med Microbiol 4(4):30–40 Atapour A, Mokarram P, MostafaviPour Z, Hosseini SY, Ghasemi Y, Mohammadi S et al (2018) Designing a fusion protein vaccine against HCV: an in silico approach. Int J Peptide Res Ther. https://doi.org/10.1007/s10989-018-9735-4 Benkert P, Tosatto SC, Schomburg D (2008) QMEAN: A comprehensive scoring function for model quality assessment. Proteins 71(1):261–277 Bhasin M, Raghava G (2004) Prediction of CTL epitopes using QM, SVM and ANN techniques. Vaccine 22(23–24):3195–3204 Blom N, Gammeltoft S, Brunak S (1999) Sequence and structure-based prediction of eukaryotic protein phosphorylation sites1. J Mol Biol 294(5):1351–1362 Blom N, Sicheritz-Pontén T, Gupta R, Gammeltoft S, Brunak S (2004) Prediction of post-translational glycosylation and phosphorylation of proteins from the amino acid sequence. Proteomics 4(6):1633–1649 Cashman SB, Marsden BD, Dustin LB (2014) The humoral immune response to HCV: understanding is key to vaccine development. Front Immunol 5:550 Caval V, Piver E, Ivanyi-Nagy R, Darlix J-L, Pagès J-C (2011) Packaging of HCV-RNA into lentiviral vector. Biochem Biophys Res Commun 414(4):808–813 Chauhan JS, Rao A, Raghava GP (2013) In silico platform for prediction of N-, O-and C-glycosites in eukaryotic protein sequences. PLoS ONE 8(6):e67008 Chen C-C, Hwang J-K, Yang J-M (2006) 2: Protein structure prediction server. Nucleic Acids Res 34(suppl_2):W152–W157 Chou P, Fasman GD (2009) Amino acid sequence. Adv Enzymol Relat Areas Mol Biol 47:45 Cristofari G, Ivanyi-Nagy R, Gabus C, Boulant S, Lavergne JP, Penin F et al (2004) The hepatitis C virus Core protein is a potent nucleic acid chaperone that directs dimerization of the viral (+) strand RNA in vitro. Nucleic Acids Res 32(8):2623–2631 Dehghani B, Rasooli I, Gargari SLM, Nadooshan MRJ, Owlia P, Nazarian S (2013) Immunogenicity of Salmonella enterica serovar Enteritidis virulence protein, InvH, and cross-reactivity of its antisera with Salmonella strains. Microbiol Res 168(2):84–90 Dehghani B, Rasooli I, Jalali-Nadoushan M, Owlia P, Rasooli Z (2014) Immunoprotectivity of Salmonella enterica serovar Enteritidis virulence protein, InvH, against Salmonella typhi. Iran J Basic Med Sci 17(8):560 Dehghani B, Ghasabi F, Hashempoor T, Joulaei H, Hasanshahi Z, Halaji M et al (2017) Functional and structural characterization of Ebola virus glycoprotein (1976–2015)—An in silico study. Int J Biomath 10(08):1750108 Dehghani B, Hashempour T, Zahra H (2019) Using immunoinformatics and structural approaches to design a novel HHV8 vaccine. Int J Peptide Res Ther; In Press Doytchinova IA, Flower DR (2007) VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines. BMC Bioinform 8(1):4 Emini EA, Hughes JV, Perlow D, Boger J (1985) Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide. J Virol 55(3):836–839 Farag RE, Arafa MM, El-Etreby S, Saudy NS, Eldeek BS, El-Alfy HA et al (2013) Human leukocyte antigen class I alleles can predict response to pegylated interferon/ribavirin therapy in chronic hepatitis C Egyptian patients. Arch Iran Med 16(2):68 Ferroni P, Mascolo G, Zaninetti M, Colzani D, Pregliasco F, Pirisi M et al (1993) Identification of four epitopes in hepatitis C virus core protein. J Clin Microbiol 31(6):1586–1591 Fishman SL, Factor SH, Balestrieri C, Fan X, DiBisceglie AM, Desai SM et al (2009) Mutations in the hepatitis C virus core gene are associated with advanced liver disease and hepatocellular carcinoma. Clin Cancer Res 15(9):3205–3213 Furui Y, Hoshi Y, Murata K, Ito K, Suzuki K, Uchida S et al (2011) Prevalence of amino acid mutation in hepatitis C virus core region among Japanese volunteer blood donors. J Med Virol 83(11):1924–1929 Gasteiger E, Hoogland C, Gattiker A, Wilkins MR, Appel RD, Bairoch A (2005) Protein identification and analysis tools on the ExPASy server. In: Walker JM (ed) The proteomics protocols handbook. Springer, New York, pp. 571–607 Gededzha MP, Mphahlele MJ, Selabe SG (2014) Prediction of T-cell epitopes of hepatitis C virus genotype 5a. Virol J 11(1):187 Geourjon C, Deleage G (1995) SOPMA: significant improvements in protein secondary structure prediction by consensus prediction from multiple alignments. Bioinformatics 11(6):681–684 Gremion C, Cerny A (2005) Hepatitis C virus and the immune system: a concise review. Rev Med Virol 15(4):235–268 Gupta R, Brunak S (2001) Prediction of glycosylation across the human proteome and the correlation to protein function. In: 2002 Biocomputing, World Scientific. pp. 310–322 Harase I, Moriyama T, Kaneko T, Kita H, Nomura M, Suzuki G et al (1995) Immune response to hepatitis C virus core protein in mice. Immunol Cell Biol 73(4):346 Hashempoor T, Bamdad T, Merat S, Janzamin E, Nemati L, Jabbari H et al (2010) Expansion of CD4+ CD25+ FoxP3+ regulatory T cells in chronic hepatitis C virus infection. Iran J Immunol 7(3):177–185 Hashempoor T, Alborzi AM, Moayedi J, Ajorloo M, Bamdad T, Sharifi AH et al (2018) A decline in anti-core + 1 antibody titer occurs in successful treatment of patients infected with hepatitis C virus. Jundishapur J Microbiol 11(2):e58294 Hashempour T, Bamdad T, Bergamini A, Lavergne JP, Haj-Sheykholeslami A, Brakier-Gingras L et al (2015) F protein increases CD4+ CD25+ T cell population in patients with chronic hepatitis C. Pathog Dis 73(4):ftv022 Horie T, Shimizu I, Horie C, Yogita S, Tashiro S, Ito S (1999) Mutations of the core gene sequence of hepatitis C virus isolated from liver tissues with hepatocellular carcinoma. Hepatol Res 13(3):240–251 Iakoucheva LM, Radivojac P, Brown CJ, O’Connor TR, Sikes JG, Obradovic Z et al (2004) The importance of intrinsic disorder for protein phosphorylation. Nucleic Acids Res 32(3):1037–1049 Idrees S, Ashfaq UA (2013) HCV infection and NS-3 serine protease inhibitors. Virol Mycol 2(112):2160–2161 Ivanyi-Nagy R, Kanevsky I, Gabus C, Lavergne J-P, Ficheux D, Penin F et al (2006) Analysis of hepatitis C virus RNA dimerization and core–RNA interactions. Nucleic Acids Res 34(9):2618–2633 Jazayeri SM, Carman WF (2005) Virus escape CTL or B cell epitopes? Hapat Mon 5(4):133–136 Karplus P, Schulz G (1985) Prediction of chain flexibility in proteins. Naturwissenschaften 72(4):212–213 Kelley LA, Sternberg MJ (2009) Protein structure prediction on the Web: a case study using the Phyre server. Nat Protoc 4(3):363 Khorrami S, Mohammadpour H, Shahzamani K, Zarif MN, Sharifi AH, Merat S et al (2015) The relationship between HLA-G and viral loads in non-responder HCV-infected patients after combined therapy with IFN-α2α and ribavirin. Hum Immunol 76(2–3):181–186 Larsen JEP, Lund O, Nielsen M (2006) Improved method for predicting linear B-cell epitopes. Immunome Re 2(1):2 Lauer GM, Walker BD (2001) Hepatitis C virus infection. N Engl J Med 345(1):41–52 Lavanchy D (2011) Evolving epidemiology of hepatitis C virus. Clin Microbiol Infect 17(2):107–115 Lechmann M, Ihlenfeldt HG, Braunschweiger I, Giers G, Jung G, Matz B et al (1996) T-and B-cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C infection and in healthy anti-hepatitis C virus—positive blood donors without viremi. Hepatology 24(4):790–795 Lu W, Ou J-h (2002) Phosphorylation of hepatitis C virus core protein by protein kinase A and protein kinase C. Virology 300(1):20–30 Ma H-C, Ku Y-Y, Hsieh Y-C, Lo S-Y (2007) Characterization of the cleavage of signal peptide at the C-terminus of hepatitis C virus core protein by signal peptide peptidase. J Biomed Sci 14(1):31–41 Martro E, Valero A, Jordana-Lluch E, Saludes V, Planas R, González-Candelas F et al (2011) Hepatitis C virus sequences from different patients confirm the existence and transmissibility of subtype 2q, a rare subtype circulating in the metropolitan area of Barcelona, Spain. J Med Virol 83(5):820–826 Moattari A, Dehghani B, Khodadad N, Tavakoli F (2015) In silico functional and structural characterization of H1N1 influenza A viruses hemagglutinin, 2010–2013, Shiraz, Iran. Acta Biotheor 63(2):183–202 Moayedi J, Hashempour T, Musavi Z, Hallaji M, Ghasabi F, Haj-Sheykholeslami A et al (2018) Comparison of IL-28B favorable genotype frequency between healthy and patients infected with HCV. Sci J Ilam Univ Med Sci 26(2):28–36 Netski DM, Mosbruger T, Depla E, Maertens G, Ray SC, Hamilton RG et al (2005) Humoral immune response in acute hepatitis C virus infection. Clin Infect Dis 41(5):667–675 Neumann-Haefelin C, Blum HE, Chisari F, Thimme R (2005) T cell response in hepatitis C virus infection. J Clin Virol 32(2):75–85 Nezafat N, Dorosti H, Zarei M, Ghasemi Y (2018) Exploring dengue proteome to design an effective epitope-based vaccine against dengue virus AU—Sabetian, Soudabeh. J Biomol Struct Dyn. https://doi.org/10.1080/07391102.2018.1491890 Oehler V, Filipe A, Montserret R, Da Costa D, Brown G, Penin F et al (2012) Structural analysis of hepatitis C virus core-E1 signal peptide and requirements for cleavage of the genotype 3a signal sequence by signal peptide peptidase. J Virol 86(15):7818–7828 Ogata S, Nagano-Fujii M, Ku Y, Yoon S, Hotta H (2002) Comparative sequence analysis of the core protein and its frameshift product, the F protein, of hepatitis C virus subtype 1b strains obtained from patients with and without hepatocellular carcinoma. J Clin Microbiol 40(10):3625–3630 Okamoto K, Mori Y, Komoda Y, Okamoto T, Okochi M, Takeda M et al (2008) Intramembrane processing by signal peptide peptidase regulates the membrane localization of hepatitis C virus core protein and viral propagation. J Virol 82(17):8349–8361 Parker J, Guo D, Hodges R (1986) New hydrophilicity scale derived from high-performance liquid chromatography peptide retention data: correlation of predicted surface residues with antigenicity and X-ray-derived accessible sites. Biochemistry 25(19):5425–5432 Pavio N, Lai MM (2003) The hepatitis C virus persistence: how to evade the immune system? J Biosci 28(3):287–304 Pene V, Hernandez C, Vauloup-Fellous C, Garaud-Aunis J, Rosenberg A (2009) Sequential processing of hepatitis C virus core protein by host cell signal peptidase and signal peptide peptidase: a reassessment. J Viral Hepat 16(10):705–715 Pirisi M, Fabris C, Toniutto P, Vitulli D, Soardo G, Falleti E et al (1995) Reactivity to B cell epitopes within hepatitis C virus core protein and hepatocellular carcinoma. Cancer Res 55(1):111–114 Polyak SJ, Klein KC, Shoji I, Miyamura T, Lingappa JR (2006) Assemble and interact: pleiotropic functions of the HCV core protein. Hepatitis C viruses: genomes and molecular biology. Horizon Bioscience, Norwich, pp. 89–119 Pourhassan A. Hepatitis C (2014) The first report in Azeri patients. Pak J Biol Sci 17(6):872–875 Roy A, Kucukural A, Zhang Y (2010) I-TASSER: a unified platform for automated protein structure and function prediction. Nat Protoc 5(4):725 Sabet LP, Taheri T, Memarnejadian A, Azad TM, Asgari F, Rahimnia R et al (2014) Immunogenicity of multi-epitope DNA and peptide vaccine candidates based on core, E2, NS3 and NS5B HCV epitopes in BALB/c mice. Hepat Mon 14(10):e22215 Saeedi A, Naderi M, Tabarraie A, Kelishdi M, Ghaemi A (2014) Enhanced immune responses of a hepatitis C virus core DNA vaccine by co-inoculating interleukin-12 expressing vector in mice. Vaccine Res 1(2):29–33 Saha S, Raghava GP (2004) BcePr(ed): prediction of continuous B-cell epitopes in antigenic sequences using physico-chemical properties. In: Saha S, Raghava GP (eds) International conference on artificial immune systems. Springer Saha S, Raghava G (2006a) Prediction of continuous B-cell epitopes in an antigen using recurrent neural network. Proteins 65(1):40–48 Saha S, Raghava G (2006b) AlgPred: prediction of allergenic proteins and mapping of IgE epitopes. Nucleic Acids Res 34(suppl_2):W202–W209 Samimi-Rad K, Sadeghi F, Amirzargar A, Eshraghian MR, Alavian SM, Rahimnia R (2015) Association of HLA class II alleles with hepatitis C virus clearance and persistence in thalassemia patients from Iran. J Med Virol 87(9):1565–1572 Sarvari J, Mojtahedi Z, Kuramitsu Y, Fattahi MR, Ghaderi A, Nakamura K et al (2014) Comparative proteomics of sera from HCC patients with different origins. Hepat Mon 14(1):e13103 Sefidi FJ, Keyvani H, Monavari SH, Alavian SM, Fakhim S, Bokharaei-Salim F (2013) Distribution of hepatitis C virus genotypes in Iranian chronic infected patients. Hepat Mon 13(1):e7991 Shih C-M, Chen C-M, Chen S-Y, Lee Y (1995) Modulation of the trans-suppression activity of hepatitis C virus core protein by phosphorylation. J Virol 69(2):1160–1171 Singh H, Raghava G (2001) ProPred: prediction of HLA-DR binding sites. Bioinformatics 17(12):1236–1237 Singh H, Raghava G (2003) ProPred1: prediction of promiscuous MHC Class-I binding sites. Bioinformatics 19(8):1009–1014 Steinmann E, Brohm C, Kallis S, Bartenschlager R, Pietschmann T (2008) Efficient trans-encapsidation of hepatitis C virus RNAs into infectious virus-like particles. J Virol 82(14):7034–7046 Strosberg AD, Kota S, Takahashi V, Snyder JK, Mousseau G (2010) Core as a novel viral target for hepatitis C drugs. Viruses 2(8):1734–1751 Takahashi K, Iwata K, Matsumoto M, Matsumoto H, Nakao K, Hatahara T et al (2001) Hepatitis C virus (HCV) genotype 1b sequences from fifteen patients with hepatocellular carcinoma: the ‘progression score’revisited. Hepatol Res 20(2):161–171 Targett-Adams P, Hope G, Boulant S, McLauchlan J (2008) Maturation of hepatitis C virus core protein by signal peptide peptidase is required for virus production. J Biol Chem 283(24):16850–16859 Tokita H, Kaufmann GR, Matsubayashi M, Okuda I, Tanaka T, Harada H et al (2000) Hepatitis C virus core mutations reduce the sensitivity of a fluorescence enzyme immunoassay. J Clin Microbiol 38(9):3450–3452 Ward S, Lauer G, Isba R, Walker B, Klenerman P (2002) Cellular immune responses against hepatitis C virus: the evidence base 2002. Clin Exp Immunol 128(2):195–203 Yassin K (2001) Unraveling the mystery of liver diseases in Egypt. Jacobs Verlag, Lage